Skip to main content

Table 4 Cumulative clinical outcomes according to early ischemic MR severity

From: Predictors and prognosis of early ischemic mitral regurgitation in the era of primary percutaneous coronary revascularisation

Variable All (n = 174; 100%) No MR (n = 95; 55%) Mild MR (n = 60; 34%) Moderate or severe MR (n = 19; 11%) P value
Death 2 (1%) 0 (0%) 1 (2%) 1 (5%) 0.13
Stroke 3 (2%) 2 (2%) 1 (2%) 0 (0%) 0.81
Re-infarction 13 (8%) 10 (11%) 2 (3%) 1 (5%) 0.23
Re-Hospitalization for CHF 2 (1%) 0 (0%) 1 (2%) 1 (5%) 0.13
Percutaneous coronary intervention 9 (5%) 6 (6%) 2 (3%) 1 (5%) 0.72
Coronary artery bypass grafting 14 (8%) 5 (6%) 4 (7%) 5 (26%) 0.008
Annuloplasty or mitral valve surgery 5 (3%) 0 (0%) 0 (0%) 5 (26%) <0.0001
MACE* 33 (19%) 15 (16%) 10 (17%) 8 (42%) 0.02
  1. *Major adverse cardiac events (MACE): defined as a combined endpoint of death, MI, stroke, re-hospitalization for congestive heart failure, PCI or CABG and mitral repair or replacement.
  2. MR: Mitral Regurgitation; CHF: Congestive Heart Failure; MACE: Major Adverse Cardiovascular Event.